首页|期刊导航|iLIVER|Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma

Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma

Zhu Chen Xingyu Chen Haiyang Hu Kai Chen Chengyou Du Heng Xiao Xiang Lan

iLIVER2025，Vol.4Issue(2)：P.105-110,6.

iLIVER2025，Vol.4Issue(2)：P.105-110,6.DOI:10.1016/j.iliver.2025.100163

Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma

Zhu Chen ¹Xingyu Chen ¹Haiyang Hu ¹Kai Chen ¹Chengyou Du ¹Heng Xiao ¹Xiang Lan¹

作者信息

1. Department of Hepatobiliary Surgery,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China
折叠

摘要

关键词

Hepatocellular carcinoma/Hepatic arterial infusion chemotherapy/Sintilimab/Bevacizumab/Conversion therapy

分类

医药卫生

引用本文复制引用

Zhu Chen,Xingyu Chen,Haiyang Hu,Kai Chen,Chengyou Du,Heng Xiao,Xiang Lan..Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma[J].iLIVER,2025,4(2):P.105-110,6.

基金项目

funded by the General Project of the Natural Science Foundation of Chongqing(cstc2021jcyj-msxmX0604) （cstc2021jcyj-msxmX0604）

the Chongqing Doctoral“Through Train”Research Program(CSTB2022BSXM-JCX0045). （CSTB2022BSXM-JCX0045）

iLIVER

ISSN：2772-9478

访问量0

下载量0

段落导航